
Cidara Therapeutics (CDTX) Earnings Dates & Reports
Cidara Therapeutics (CDTX) Most Recent Earnings
Report DateAug 7, 2025
Period EndingQ2 2025
Est. EPS-$1.85
Actual EPS-$1.65
EarningsBeat
Cidara Therapeutics (CDTX) Earnings
View the latest Cidara Therapeutics (CDTX) earnings report, listen to the earnings call, and analyze historical earnings performance with AI-powered insights.
Start investing in Cidara Therapeutics (CDTX)
Order type
Buy in
Order amount
Est. shares
0 shares
Cidara Therapeutics (CDTX) Earnings per Share (EPS) History
Signup for full accessBrowse free
Cidara Therapeutics (CDTX) Latest Earnings
The value each CDTX share was expected to gain vs. the value each share gained.
Cidara Therapeutics (CDTX) reported its most recent earnings on Aug 7, 2025 for Q2 2025, posting earnings per share (EPS) of -$1.65. This exceeded analysts' expectations of -$1.85 by 10.81%, marking a Beat.
For comparison, Cidara Therapeutics reported EPS of -$2.05 in the same quarter last year.
The company is expected to announce its next earnings report on 11/06/2025, with analysts projecting an EPS of -$1.30.
Cidara Therapeutics (CDTX) Earnings History
Earnings | Est. EPS | Actual EPS | Surprise | |
---|---|---|---|---|
Q3 2025Nov 6, 2025 | -$1.30 | Next earnings call Nov. 6, 2025 | ||
Q2 2025Aug 7, 2025 | -$1.85 | -$1.65 | -10.81% | |
Q1 2025May 8, 2025 | -$3.47 | -$1.66 | -52.16% | |
Q4 2024Mar 6, 2025 | -$4.10 | -$5.38 | +31.22% | |
Q3 2024Nov 7, 2024 | -$4.25 | -$2.38 | -44.00% | |
Cidara Therapeutics (CDTX) Earnings Related Price Changes
Earnings announcements may impact a stock’s price. This table highlights the Cidara Therapeutics’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.
Report date | Price 1D before | Price 1D after | Change |
---|---|---|---|
Aug 7, 2025 | — | — | — |
May 8, 2025 | — | — | — |
Mar 6, 2025 | — | — | — |
Nov 7, 2024 | — | — | — |
Cidara Therapeutics (CDTX) Earnings FAQs
Cidara Therapeutics (CDTX) last reported earnings on Aug 7, 2025 for Q2 2025, posting an EPS of -$1.65, which Beat the estimate of -$1.85 by 10.81%.
For Q2 2025, Cidara Therapeutics (CDTX) reported an EPS of -$1.65, exceeding analysts' estimate of -$1.85 by 10.81%.
For Q2 2025, Cidara Therapeutics (CDTX) Beat expectations with an actual EPS of -$1.65 vs. an estimated EPS of -$1.85.
Following the last earnings report on Aug 7, 2025, Cidara Therapeutics (CDTX)'s stock price moved — from — to —.
The next Cidara Therapeutics (CDTX) earnings call is scheduled for Nov. 6, 2025, where executives will discuss financial results and outlook.